Accendra Health, Inc. Proceeds from Long-term Lines of Credit
Accendra Health, Inc. (ACH) reported Proceeds from Long-term Lines of Credit of $548.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-08-10
- Accendra Health, Inc. proceeds from long-term lines of credit for the quarter ending 2026-06-30 was $279.50M, a 67.24% decline year-over-year.
- Accendra Health, Inc. proceeds from long-term lines of credit for the quarter ending 2026-03-31 was $269.10M, a 65.37% decline year-over-year.
- Accendra Health, Inc. proceeds from long-term lines of credit for the quarter ending 2025-12-31 was $472.30M, a 25.72% decline year-over-year.
- Accendra Health, Inc. proceeds from long-term lines of credit for the quarter ending 2025-09-30 was $812.30M.
- Accendra Health, Inc. proceeds from long-term lines of credit for fiscal 2025 was $2.91B, a 358.44% increase from fiscal 2024.
- Accendra Health, Inc. proceeds from long-term lines of credit for fiscal 2024 was $635.80M.
- Accendra Health, Inc. proceeds from long-term lines of credit for fiscal 2023 was $0.00.
- Accendra Health, Inc. proceeds from long-term lines of credit for fiscal 2022 was $0.00.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $279.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $548.60M 10-Q · filed 2026-08-10 | $1.02B derived: sum of 3 quarters · filed 2026-08-10 | $1.83B derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $269.10M 10-Q · filed 2026-05-11 | $741.40M derived: sum of 2 quarters · filed 2026-05-11 | $1.55B derived: sum of 3 quarters · filed 2026-05-11 | $2.41B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $472.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.28B derived: sum of 2 quarters · filed 2026-02-20 | $2.14B derived: sum of 3 quarters · filed 2026-08-10 | $2.91B 10-K · filed 2026-02-20 |
| 2025-09-30 | $812.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $1.67B derived: sum of 2 quarters · filed 2026-08-10 | $2.44B 10-Q · filed 2025-10-31 | $3.08B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $853.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.63B 10-Q · filed 2026-08-10 | $2.27B derived: sum of 3 quarters · filed 2026-08-10 | $2.27B derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $776.98M 10-Q · filed 2026-05-11 | $1.41B derived: sum of 2 quarters · filed 2026-05-11 | $1.41B derived: sum of 3 quarters · filed 2026-05-11 | $1.41B derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $635.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $635.80M derived: sum of 2 quarters · filed 2026-02-20 | $635.80M derived: sum of 3 quarters · filed 2026-02-20 | $635.80M 10-K · filed 2026-02-20 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $0.00 derived: sum of 2 quarters · filed 2025-10-31 | $0.00 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |